Fig. 7: SKA3 expression is correlated with clinicopathological features and poor prognosis.
From: SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma

a Immunohistochemical staining showed elevated SKA3 expression in HCC tissues compared to corresponding normal liver tissues in 236 pairs of clinical samples. Scale bars: 100 μm. b, c Overall survival and disease-free survival curves showed that patients with high expression levels of SKA3 have worse prognosis. d, e Overall survival and disease-free survival curves showed that patients with high expression levels of SKA3 and P53 have worse prognosis.